Precigen (PGEN) Return on Invested Capital Growth (3y) (2017 - 2023)
Precigen (PGEN) Return on Invested Capital Growth (3y) (2017 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 2.00 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 3.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Precigen | 1.95 Bn | 1.95 Bn | 20.69 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 245.00 |
| Sep 30, 2023 | 306.00 |
| Jun 30, 2023 | 364.00 |
| Mar 31, 2023 | 110.00 |
| Dec 31, 2022 | 67.00 |
| Sep 30, 2022 | 134.00 |
| Jun 30, 2022 | 29.00 |
| Mar 31, 2022 | 61.00 |
| Dec 31, 2021 | 146.00 |
| Sep 30, 2021 | -83.00 |
| Jun 30, 2021 | -233.00 |
| Mar 31, 2021 | -230.00 |
| Dec 31, 2020 | -189.00 |
| Sep 30, 2020 | -255.00 |
| Jun 30, 2020 | -315.00 |
| Mar 31, 2020 | -67.00 |
| Dec 31, 2019 | -20.00 |
| Sep 30, 2019 | -85.00 |
| Jun 30, 2019 | -124.00 |
| Mar 31, 2019 | -161.00 |